Darier disease: A disease model of impaired calcium homeostasis in the skin

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 1111-1117

  Savignac, Magali ^a,b   Edir, Anissa ^a,c   Simon, Marina ^a,c   Hovnanian, Alain ^a,c,d  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Adhesion; Calcium; Darier; Differentiation; Keratinocytes; SERCA2

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

APOPTOSIS; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DIFFERENTIATION; DARIER DISEASE; DESMOSOME; ENDOPLASMIC RETICULUM STRESS; EPIDERMIS; EXTRACELLULAR CALCIUM; GENE MUTATION; HUMAN; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; CALCIUM; DARIER DISEASE; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SKIN;

EID: 79955659952     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.12.006     Document Type: Review

References (71)

1. Hovnanian A. Acantholytic disorders of the skin: Darier-White, Acrokeratosis Verruciformis, Grover disease, and Hailey-Hailey disease. Dermatology in General Medicine 2007, 432-442. McGraw Hill ed, Chap 49. A. Fitzpatrick (Ed.).
2. 2+ pump, cause Darier disease. Nat. Genet. 1999, 21:271-277.
3. Hovnanian A. SERCA pumps and human diseases. Subcell. Biochem. 2007, 45:337-363.
4. Dode L., Andersen J.P., Leslie N., Dhitavat J., Vilsen B., Hovnanian A. Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+ -ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses. J. Biol. Chem. 2003, 278:47877-47889.
5. 2+ response and cell viability in Darier disease. J. Cell Sci. 2006, 119:671-679.
6. Leinonen P.T., Myllyla R.M., Hagg P.M., Tuukkanen J., Koivunen J., Peltonen S., Oikarinen A., Korkiamaki T., Peltonen J. Keratinocytes cultured from patients with Hailey-Hailey disease and Darier disease display distinct patterns of calcium regulation. Br. J. Dermatol. 2005, 153:113-117.
7. Lytton J., Westlin M., Burk S.E., Shull G.E., MacLennan D.H. Functionalcomparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J. Biol. Chem. 1992, 267:14483-14489.
8. Lytton J., MacLennan D.H. Molecular cloning of cDNAs from human kidneycoding for two alternatively spliced products of the cardiac Ca2+-ATPase gene. J. Biol. Chem. 1988, 263:15024-15031.
9. Gelebart P., Martin V., Enouf J., Papp B. Identification of a new SERCA2 splice variant regulated during monocytic differentiation. Biochem. Biophys. Res. Commun. 2003, 303:676-684.
10. Ruiz-Perez V.L., Carter S.A., Healy E., Todd C., Rees J.L., Steijlen P.M., Carmichael A.J., Lewis H.M., Hohl D., Itin P., Vahlquist A., Gobello T., Mazzanti C., Reggazini R., Nagy G., Munro C.S., Strachan T. ATP2A2 mutations in Darier's disease: variant cutaneous phenotypes are associated with missense mutations, but neuropsychiatric features are independent of mutation class. Hum. Mol. Genet. 1999, 8:1621-1630.
11. Lompre A.M., de la Bastie D., Boheler K.R., Schwartz K. Characterization and expression of the rat heart sarcoplasmic reticulum Ca2+-ATPase mRNA. FEBS Lett. 1989, 249:35-41.
12. 2+]i waves. J. Biol. Chem. 1997, 272:15765-15770.
13. 2+ transport ATPase SERCA2isoforms in the cat brain. Brain Res. 1996, 743:141-153.
14. Dally S., Bredoux R., Corvazier E., Andersen J.P., Clausen J.D., Dode L., Fanchaouy M., Gelebart P., Monceau V., Del Monte F., Gwathmey J.K., Hajjar R., Chaabane C., Bobe R., Raies A., Enouf J. Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+ -ATPase 2 isoform. Biochem. J. 2006, 395:249-258.
15. Verboomen H., Wuytack F., De Smedt H., Himpens B., Casteels R. Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban. Biochem. J. 1992, 286(Pt 2):591-595.
16. 2+)- ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ. Res. 2001, 89:838-846.
17. 2+ pump. Proc. Natl Acad. Sci. USA 2009, 106:18533-18538.
18. Dhitavat J., Macfarlane S., Dode L., Leslie N., Sakuntabhai A., MacSween R., Saihan E., Hovnanian A. Acrokeratosis verruciformis of Hopf is caused by mutationin ATP2A2: evidence that it is allelic to Darier's disease. J. Invest. Dermatol. 2003, 120:229-232.
19. Ikeda S., Mayuzumi N., Shigihara T., Epstein E.H., Goldsmith L.A., Ogawa H. Mutations in ATP2A2 in patients with Darier's disease. J. Invest. Dermatol. 2003, 121:475-477.
20. Miyauchi Y., Daiho T., Yamasaki K., Takahashi H., Ishida-Yamamoto A., Danko S., Suzuki H., Iizuka H. Comprehensive analysis of expression and functionof 51 sarco(endo)plasmic reticulum Ca2+-ATPase mutants associated with Darier disease. J. Biol. Chem. 2006, 281:22882-22895.
21. Ahn W., Lee M.G., Kim K.H., Muallem S. Multiple effects of SERCA2b mutations associated with Darier's disease. J. Biol. Chem. 2003, 278:20795-20801.
22. Sheridan A.T., Hollowood K., Sakuntabhai A., Dean D., Hovnanian A., Burge S. Expression of sarco/endo-plasmic reticulum Ca2+-ATPase type 2 isoforms (SERCA2) in normal human skin and mucosa, and Darier's disease skin. Br. J. Dermatol. 2002, 147:670-674.
23. Fuchs E., Raghavan S. Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet. 2002, 3:199-209.
24. 2+) shift. Exp. Cell Res. 2002, 276:296-309.
25. Elias P.M., Ahn S.K., Denda M., Brown B.E., Crumrine D., Kimutai L.K., Komuves L., Lee S.H., Feingold K.R. Modulations in epidermal calcium regulate the expression of differentiation-specific markers. J. Invest. Dermatol. 2002, 119:1128-1136.
26. Foggia L., Hovnanian A. Calcium pump disorders of the skin. Am. J. Med. Genet. C Semin. Med. Genet. 2004, 131C:20-31.
27. Menon G.K., Elias P.M., Lee S.H., Feingold K.R. Localization of calcium in murine epidermis following disruption and repair of the permeability barrier. Cell Tissue Res. 1992, 270:503-512.
28. 2+ and K+gradients in murine epidermis: quantitative measurement using PIXE. J. Invest. Dermatol. 1998, 111:1198-1201.
29. Tsutsumi M., Denda S., Inoue K., Ikeyama K., Denda M. Calcium ion gradients and dynamics in cultured skin slices of rat hindpaw in response to stimulation with ATP. J. Invest. Dermatol. 2009, 129:584-589.
30. Denda M., Tsuchiya T., Elias P.M., Feingold K.R. Stress alters cutaneous permeability barrier homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R367-R372.
31. A. Celli, S. Sanchez, M. Behne, T. Hazlett, E. Gratton, T. Mauro, The epidermal Ca(2+) gradient: Measurement using the phasor representation of fluorescent lifetime imaging. Biophys J 98; 911-921.
32. Ambudkar I.S. TRPC1: a core component of store-operated calcium channels. Biochem. Soc. Trans. 2007, 35:96-100.
33. Prakriya M., Lewis R.S. CRAC channels: activation, permeation, and the searchfor a molecular identity. Cell Calcium 2003, 33:311-321.
34. 2+ entry channels: still elusive!. Sci. STKE 2004, 2004:e36.
35. Clapham D.E. Sorting out MIC, TRP, and CRAC ion channels. J Gen Physiol 2002, 120:217-220.
36. Voets T., Prenen J., Fleig A., Vennekens R., Watanabe H., Hoenderop J.G., Bindels R.J., Droogmans G., Penner R., Nilius B. CaT1 and the calcium release- activated calcium channel manifest distinct pore properties. J. Biol. Chem. 2001, 276:47767-47770.
37. Cahalan M.D., Zhang S.L., Yeromin A.V., Ohlsen K., Roos J., Stauderman K.A. Molecular basis of the CRAC channel. Cell Calcium 2007, 42:133-144.
38. Feske S. Calcium signalling in lymphocyte activation and disease. Nat. Rev. Immunol. 2007, 7:690-702.
39. Luik R.M., Wang B., Prakriya M., Wu M.M., Lewis R.S. Oligomerization of STIM1couples ER calcium depletion to CRAC channel activation. Nature 2008, 454:538-542.
40. 2+ store depletion. Proc. Natl Acad. Sci. USA 2007, 104:9301-9306.
41. M. Lu, R. Branstrom, E. Berglund, A. Hoog, P. Bjorklund, G. Westin, C. Larsson, L.O. Farnebo, L. Forsberg, Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid. J Mol Endocrinol 44: 285-294.
42. Liao Y., Erxleben C., Yildirim E., Abramowitz J., Armstrong D.L., Birnbaumer L. Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc. Natl Acad. Sci. USA 2007, 104:4682-4687.
43. 2+ entry in mesangial cells. Exp. Biol. Med. (Maywood) 2009, 234:673-682.
44. 2+ ATPase 2 gene silencing promotes cell survival: a potential role for TRPC1 in Darier's disease. Mol. Biol. Cell 2006, 17:4446-4458.
45. Leinonen P.T., Hagg P.M., Peltonen S., Jouhilahti E.M., Melkko J., Korkiamaki T., Oikarinen A., Peltonen J. Reevaluation of the normal epidermal calcium gradient, and analysis of calcium levels and ATP receptors in Hailey- Hailey and Darier epidermis. J. Invest. Dermatol. 2009, 129:1379-1387.
46. Yoshida H. ER stress and diseases. FEBS J. 2007, 274:630-658.
47. Hovnanian A. Darier's disease: from dyskeratosis to endoplasmic reticulum calcium ATPase deficiency. Biochem. Biophys. Res. Commun. 2004, 322:1237-1244.
48. Mayuzumi N., Ikeda S., Kawada H., Fan P.S., Ogawa H. Effects of ultraviolet B irradiation, proinflammatory cytokines and raised extracellular calcium concentration on the expression of ATP2A2 and ATP2C1. Br. J. Dermatol. 2005, 152:697-701.
49. Onozuka T., Sawamura D., Goto M., Yokota K., Shimizu H. Possible role ofendoplasmic reticulum stress in the pathogenesis of Darier's disease. J. Dermatol. Sci. 2006, 41:217-220.
50. Bongiorno M.R., Arico M. The behaviour of Bcl-2, Bax and Bcl-x in Darier's disease. Br. J. Dermatol. 2002, 147:696-700.
51. Pasmatzi E., Badavanis G., Monastirli A., Tsambaos D. Reduced expression of the antiapoptotic proteins of Bcl-2 gene family in the lesional epidermis of patients with Darier's disease. J. Cutan. Pathol. 2007, 34:234-238.
52. Burge S.M., Garrod D.R. An immunohistological study of desmosomes in Darier's disease and Hailey-Hailey disease. Br. J. Dermatol. 1991, 124:242-251.
53. Stuart R.O., Sun A., Bush K.T., Nigam S.K. Dependence of epithelial intercellular junction biogenesis on thapsigargin-sensitive intracellular calcium stores. J. Biol. Chem. 1996, 271:13636-13641.
54. Kanitakis J., Zambruno G., Viac J., Thivolet J. Involucrin expression inkeratinization disorders of the skin - a preliminary study. Br. J. Dermatol. 1987, 117:479-486.
55. Kassar S., Charfeddine C., Zribi H., Tounsi-Kettiti H., Bchetnia M., Jerbi E., Cassio D., Mokni M., Abdelhak S., Ben Osman A., Boubaker S. Immunohistological study of involucrin expression in Darier's disease skin. J. Cutan. Pathol. 2008, 35:635-640.
56. Ishida-Yamamoto A., Iizuka H., Manabe M., O'Guin W.M., Hohl D., Kartasova T., Kuroki T., Roop D.R., Eady R.A. Altered distribution of keratinization markers in epidermolytic hyperkeratosis. Arch. Dermatol. Res. 1995, 287:705-711.
57. Jensen J.M., Folster-Holst R., Baranowsky A., Schunck M., Winoto-Morbach S., Neumann C., Schutze S., Proksch E. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J. Invest. Dermatol. 2004, 122:1423-1431.
58. Hohl D., Huber M., Frenk E. Analysis of the cornified cell envelope in lamellar ichthyosis. Arch. Dermatol. 1993, 129:618-624.
59. Pena-Penabad C., de Unamuno P., Garcia Silva J., Ludena M.D., GonzalezSarmiento R., Perez-Arellano J.L. Altered expression of immunoreactive involucrinin lamellar ichthyosis. Eur. J. Dermatol. 1999, 9:197-201.
60. Jackson B., Tilli C.M., Hardman M.J., Avilion A.A., MacLeod M.C., Ashcroft G.S., Byrne C. Late cornified envelope family in differentiating epithelia-response to calcium and ultraviolet irradiation. J. Invest. Dermatol. 2005, 124:1062-1070.
61. Gordon-Smith K., Jones L.A., Burge S.M., Munro C.S., Tavadia S., Craddock N. The neuropsychiatric phenotype in Darier disease. Br. J. Dermatol. 2010.
62. Burge S.M., Wilkinson J.D. Darier-White disease: a review of the clinicalfeatures in 163 patients. J. Am. Acad. Dermatol. 1992, 27:40-50.
63. Burge S. Darier's disease-the clinical features and pathogenesis. Clin. Exp. Dermatol. 1994, 19:193-205.
64. Tavadia S., Tait R.C., McDonagh T.A., Munro C.S. Platelet and cardiac functionin Darier's disease. Clin. Exp. Dermatol. 2001, 26:696-699.
65. Mayosi B.M., Kardos A., Davies C.H., Gumedze F., Hovnanian A., Burge S., Watkins H. Heterozygous disruption of SERCA2a is not associated with impairmentof cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure. Heart 2006, 92:105-109.
66. Tavadia S., Authi K.S., Hodgins M.B., Munro C.S. Expression of thesarco/endoplasmic reticulum calcium ATPase type 2 and 3 isoforms in normal skin and Darier's disease. Br. J. Dermatol. 2004, 151:440-445.
67. Periasamy M., Reed T.D., Liu L.H., Ji Y., Loukianov E., Paul R.J., Nieman M.L., Riddle T., Duffy J.J., Doetschman T., Lorenz J.N., Shull G.E. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J. Biol. Chem. 1999, 274:2556-2562.
68. 2+ signaling and Ca2+-dependent exocytosis in SERCA2(+/-) mice. Embo 2001, J20:2680-2689.
69. 2+ pump. J. Biol. Chem. 2001, 276:26737-26740.
70. 2+ pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility. Cancer Res. 2005, 65:8655-8661.
71. Serca2 gene. J. Mol. Cell. Cardiol. 2009, 47:180-187.